Carbonic anhydrase inhibitors and activators for novel therapeutic applications. - Wikidata - awgldk - TriplyDB

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

http://www.wikidata.org/entity/Q37909406

about

Legionella pneumophila Carbonic Anhydrases: Underexplored Antibacterial Drug Targets Alkyne-azide "click" chemistry in designing nanocarriers for applications in biology Bioactive heterocycles containing endocyclic N-hydroxy groups Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors Functionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrases PubChem structure–activity relationship (SAR) clusters Synthesis of 4-[2-(3,4-dimethoxybenzyl)cyclopentyl]-1,2-dimethoxybenzene Derivatives and Evaluations of Their Carbonic Anhydrase Isoenzymes Inhibitory Effects.A class of carbonic anhydrase I - selective activators.Carbonic anhydrase inhibitor attenuates ischemia-reperfusion induced acute lung injury.Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage.Type III Methyltransferase M.NgoAX from Neisseria gonorrhoeae FA1090 Regulates Biofilm Formation and Interactions with Human Cells.Heterocyclic urea derivatives and methods of use thereof (WO2010142978).The role of carbonic anhydrase IX in hypoxia control in OSCC.Structure-based drug discovery of carbonic anhydrase inhibitors.Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review.Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors.Antiglaucoma carbonic anhydrase inhibitors: a patent review.Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors.The η-class carbonic anhydrases as drug targets for antimalarial agents.How many carbonic anhydrase inhibition mechanisms exist?Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity.Catalytic activity of human carbonic anhydrase isoform IX is displayed both extra- and intracellularly.Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy A failed tentative to design a super carbonic anhydrase having the biochemical properties of the most thermostable CA (SspCA) and the fastest (SazCA) enzymes.Protonography, a technique applicable for the analysis of η-carbonic anhydrase activity.Expression of the CHOP-inducible carbonic anhydrase CAVI-b is required for BDNF-mediated protection from hypoxia.Carbonic anhydrase inhibitors: design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives.Sulfonamides with Potent Inhibitory Action and Selectivity against the α-Carbonic Anhydrase from Vibrio cholerae.Biomimetic CO2 capture using a highly thermostable bacterial α-carbonic anhydrase immobilized on a polyurethane foam.The use of CA-IX as a diagnostic method for oral leukoplakia.Synthesis and carbonic anhydrase inhibitory properties of novel 1,4-dihydropyrimidinone substituted diarylureas.Biochemical properties of a new α-carbonic anhydrase from the human pathogenic bacterium, Vibrio cholerae.2-Amino-3-cyanopyridine derivatives as carbonic anhydrase inhibitors.Synthesis of aminocyanopyrazoles via a multi-component reaction and anti-carbonic anhydrase inhibitory activity of their sulfamide derivatives against cytosolic and transmembrane isoforms.Synthesis and carbonic anhydrase inhibitory properties of tetrazole- and oxadiazole substituted 1,4-dihydropyrimidinone compounds.Synthesis and carbonic anhydrase inhibitory properties of 1,3-dicarbonyl derivatives of methylaminobenzene-sulfonamide.Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX.Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis.

P2860

Q26744302-1385C401-0926-4538-A600-109A5CCCA1E6 Q26995503-B3012133-B206-4079-A361-C97B01745173 Q27025241-8BD7E105-FDA1-49CE-92AF-CE7B21E22F15 Q27674538-2520927C-5BBE-44EC-8DEB-F55EFD7370F1 Q27676887-7ED3FCE7-2108-441E-AEC9-6832CEE0F547 Q27681860-E645EB28-F2CC-4F19-832C-6F63361F65FA Q27698200-34B4E7AC-8DDE-4109-BB1E-AA0E283B731D Q27902296-FE85EC92-F837-4454-A853-973F0D760386 Q31030668-3E88D4B5-7EF4-44BF-AAC9-3592304F0AA2 Q31140231-B070DD3B-8312-4FE4-B612-540F513AB853 Q33828957-E9724759-24EE-4F0D-92AF-B91CB8FF47C8 Q35726195-D7CA298B-EDA3-4395-BE27-3033D42F8398 Q36387438-9C1F0A1C-C8D7-4AF5-A3C1-47BD8E4A8FFA Q37849468-D7D1A17B-75EC-4AAE-9C41-746935D099A7 Q37993617-EFD6F34A-6A7D-431A-92B7-0C99F73EF65A Q37999063-FB703E21-5483-4FE7-BDD7-6A53EE5778E0 Q38091452-8AE74363-E972-4BD4-8209-1F0042581BCE Q38102745-0F4E8D21-4221-42B6-ACD3-7DE05AD4F3DC Q38102786-0E64D445-5A66-40DD-B502-7A73ACA1FB3F Q38221060-CA93EF43-F708-4F2E-9322-17736A851167 Q38286239-5A2DEE63-9E0D-45D5-9DA9-11B622B78306 Q38653464-06F8B067-8987-42A3-80CC-0908823FB77F Q38742510-7A035DCC-B054-4055-8A56-22E8E576EB6D Q38827659-B1B63324-94A7-43A6-8D54-D94AD0944076 Q41109846-C0035A17-8093-47EC-BE48-127541D5809C Q41434488-49D9D7F8-BE77-4197-9034-4437927B0CF2 Q41486816-1CAEBFCF-9E6E-4C2A-86BA-7A3BCD549316 Q41865751-9519CBC8-D913-4891-A7A3-E12DB6CAE504 Q41889149-AB2261F5-2F81-4E7F-8DEB-885073004C83 Q42280107-F201F396-E466-410B-809B-028A8B0685BC Q43017687-0661AAAD-41CA-4798-B393-FB5960278A7C Q43324335-13D04DF9-D5B0-4799-9BBF-1FD21681F0E9 Q43621607-AB5EC39F-6703-41A8-A7FE-0006894428F8 Q43975307-9B045D3E-46E6-46F6-A035-4A4859B814B5 Q44092648-0EBA8DAB-26B1-4989-B612-A8AD16258FEB Q44185596-F2C58147-C18A-43AA-9747-F5359BB46488 Q44340343-15E98168-487D-4196-87C4-A9EAEB88089B Q44510176-4C2540E6-C9CE-40A4-B26D-A2AD21292047 Q44782160-FA84D70A-2C2D-46D5-AA29-FF2A361BFEA9 Q44803551-1388D3F2-E994-4FF1-9A87-26AAB6D0DF89

P2860

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

http://www.wikidata.org/entity/Q37909406

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

@en

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

@nl

type

label

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

@en

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

@nl

prefLabel

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

@en

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

@nl

P1433

Q37909406-F2F48024-0E0C-4565-933B-B1A1EF49748C

P1476

Q37909406-E2ED8D85-3EA8-4479-BD21-1A72B58A51E4

P2093

Q37909406-2B06FD99-5364-440F-B94F-6336A35D385D

P2860

Q37909406-007A17E8-1A92-4C6C-9349-3BF29999C80D

Q37909406-04FA4F7F-33B8-4273-A644-E0BB9C24E7CF

Q37909406-0C546B59-C604-4AF8-ADDB-5402542B8BD4

Q37909406-0E4DC9E6-61F6-49E3-9341-BEAB6FADA3F8

Q37909406-0EAB927B-8200-400A-8292-EC058C48EE4D

Q37909406-12FDBC7D-108C-4827-B93C-652A760ADDB7

Q37909406-13B0BEB2-0C54-4F3E-BFA4-696AFF691D68

Q37909406-146063A8-1E4D-4198-8D31-6E1062E10D3A

Q37909406-1A79AA1A-B06E-4E54-A037-165BE0DA63CB

Q37909406-1BC04565-0F92-4AE1-B3E1-46CBCC1E2CA1

P304

Q37909406-F7E9A34C-1D1F-4D50-9831-5532B00A48C7

P31

Q37909406-7DEA4FA1-597D-4A4D-8078-6ED481DF6FD9

P356

Q37909406-2A2F230D-3CF1-4B82-AF35-0142B2F6D7CC

P433

Q37909406-80C03CB8-6B7B-44EA-9225-47082B401ADB

P478

Q37909406-D7FBCBD7-7F3F-4A0B-978C-337A360207E9

P577

Q37909406-C3118B88-9915-47DC-9D0F-27EDB7088AEC

P698

Q37909406-91AA5341-BC88-4A9D-8DF3-D4942E848D7D

P356

P1433

Future Medicinal Chemistry

P1476

Carbonic anhydrase inhibitors and activators for novel therapeutic applications.

@en

P2093

Claudiu T Supuran

http://www.w3.org/2001/XMLSchema#string

P2860

Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition

Inhibition of carbonic anhydrase II by thioxolone: a mechanistic and structural study

Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms

Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct

Carbonic anhydrase activators: kinetic and X-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV

Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans

Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide X-ray crystal structures in adducts with isozyme II: when three water molecules and the keto-enol tautomerism make the difference

A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alpha-carbonic anhydrases

Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors

Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX

P304

1165-1180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.11.69

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21806379

http://www.w3.org/2001/XMLSchema#string